Annual Shareholders Equity
$10.36 B
-$6.89 B-39.96%
31 December 2023
Summary:
AbbVie annual stockholders equity is currently $10.36 billion, with the most recent change of -$6.89 billion (-39.96%) on 31 December 2023. During the last 3 years, it has fallen by -$2.72 billion (-20.77%). ABBV annual shareholders equity is now -39.96% below its all-time high of $17.25 billion, reached on 31 December 2022.ABBV Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$6.03 B
-$746.00 M-11.01%
30 September 2024
Summary:
AbbVie quarterly stockholders equity is currently $6.03 billion, with the most recent change of -$746.00 million (-11.01%) on 30 September 2024. Over the past year, it has dropped by -$6.06 billion (-50.12%). ABBV quarterly shareholders equity is now -65.04% below its all-time high of $17.25 billion, reached on 31 December 2022.ABBV Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABBV Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -40.0% | -50.1% |
3 y3 years | -20.8% | -55.5% |
5 y5 years | +222.7% | +173.3% |
ABBV Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -40.0% | at low | -65.0% | at low |
5 y | 5 years | -40.0% | +222.7% | -65.0% | +173.3% |
alltime | all time | -40.0% | +222.7% | -65.0% | +170.4% |
AbbVie Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $6.03 B(-11.0%) |
June 2024 | - | $6.78 B(-15.3%) |
Mar 2024 | - | $8.01 B(-22.7%) |
Dec 2023 | $10.36 B(-40.0%) | $10.36 B(-14.3%) |
Sept 2023 | - | $12.09 B(-6.0%) |
June 2023 | - | $12.87 B(-3.1%) |
Mar 2023 | - | $13.27 B(-23.1%) |
Dec 2022 | $17.25 B(+12.0%) | $17.25 B(+7.9%) |
Sept 2022 | - | $15.99 B(+9.2%) |
June 2022 | - | $14.65 B(-10.0%) |
Mar 2022 | - | $16.28 B(+5.7%) |
Dec 2021 | $15.41 B(+17.8%) | $15.41 B(+13.7%) |
Sept 2021 | - | $13.55 B(+7.8%) |
June 2021 | - | $12.57 B(-8.3%) |
Mar 2021 | - | $13.71 B(+4.8%) |
Dec 2020 | $13.08 B(-260.0%) | $13.08 B(-14.4%) |
Sept 2020 | - | $15.27 B(+3.8%) |
June 2020 | - | $14.71 B(-298.4%) |
Mar 2020 | - | -$7.42 B(-9.3%) |
Dec 2019 | -$8.17 B(-3.2%) | -$8.17 B(-0.7%) |
Sept 2019 | - | -$8.23 B(-4.0%) |
June 2019 | - | -$8.57 B(+9.5%) |
Mar 2019 | - | -$7.83 B(-7.3%) |
Dec 2018 | -$8.45 B | -$8.45 B(+189.1%) |
Sept 2018 | - | -$2.92 B(-13.5%) |
June 2018 | - | -$3.38 B(-195.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $3.55 B(-30.3%) |
Dec 2017 | $5.10 B(+9.9%) | $5.10 B(-23.8%) |
Sept 2017 | - | $6.69 B(+11.3%) |
June 2017 | - | $6.01 B(+20.2%) |
Mar 2017 | - | $5.00 B(+7.8%) |
Dec 2016 | $4.64 B(+17.5%) | $4.64 B(-28.3%) |
Sept 2016 | - | $6.47 B(+14.7%) |
June 2016 | - | $5.64 B(+21.5%) |
Mar 2016 | - | $4.64 B(+17.7%) |
Dec 2015 | $3.94 B(+126.5%) | $3.94 B(-18.9%) |
Sept 2015 | - | $4.86 B(-11.6%) |
June 2015 | - | $5.50 B(+299.7%) |
Mar 2015 | - | $1.38 B(-21.0%) |
Dec 2014 | $1.74 B(-61.2%) | $1.74 B(-62.5%) |
Sept 2014 | - | $4.64 B(-11.0%) |
June 2014 | - | $5.22 B(+11.1%) |
Mar 2014 | - | $4.70 B(+4.6%) |
Dec 2013 | $4.49 B(+33.6%) | $4.49 B(+25.6%) |
Sept 2013 | - | $3.58 B(+0.5%) |
June 2013 | - | $3.56 B(+20.3%) |
Mar 2013 | - | $2.96 B(-12.1%) |
Dec 2012 | $3.36 B(-71.8%) | $3.36 B(-78.5%) |
Sept 2012 | - | $15.67 B(+36.2%) |
June 2012 | - | $11.51 B(-4.5%) |
Mar 2012 | - | $12.05 B(+1.0%) |
Dec 2011 | $11.93 B(-24.0%) | $11.93 B |
Dec 2010 | $15.70 B | - |
FAQ
- What is AbbVie annual stockholders equity?
- What is the all time high annual shareholders equity for AbbVie?
- What is AbbVie annual shareholders equity year-on-year change?
- What is AbbVie quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for AbbVie?
- What is AbbVie quarterly shareholders equity year-on-year change?
What is AbbVie annual stockholders equity?
The current annual shareholders equity of ABBV is $10.36 B
What is the all time high annual shareholders equity for AbbVie?
AbbVie all-time high annual stockholders equity is $17.25 B
What is AbbVie annual shareholders equity year-on-year change?
Over the past year, ABBV annual stockholders equity has changed by -$6.89 B (-39.96%)
What is AbbVie quarterly stockholders equity?
The current quarterly shareholders equity of ABBV is $6.03 B
What is the all time high quarterly shareholders equity for AbbVie?
AbbVie all-time high quarterly stockholders equity is $17.25 B
What is AbbVie quarterly shareholders equity year-on-year change?
Over the past year, ABBV quarterly stockholders equity has changed by -$6.06 B (-50.12%)